Search research articles
Contact Us
Filters
Showing results (51-60 of 98) with videos related to
Page
of 10
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 15, 2018
Prioritizing topics in guideline development: results of a two-phase online survey of dermatologist members of the EADV
A Nast, M Gaskins, L Eisert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 12, 2010
On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: structure and challenges
D Pathirana, A Nast, A D Ormerod, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 21, 2009
A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: 'AGREE-ing' on a common base for European evidence-based psoriasis treatment guidelines
A Nast, P H Spuls, A D Ormerod, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 16, 2015
The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrument
R N Werner, B Marinović, S Rosumeck, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 26, 2017
Methods report: European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC
C Dressler, S Rosumeck, R N Werner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 13, 2012
Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment
T C Lucka, D Pathirana, A Sammain, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 11, 2005
Reporting and classification of patient safety events in a cardiothoracic intensive care unit and cardiothoracic postoperative care unit
Patricia A Nast, Michael Avidan, Carolyn B Harris, et al.
The British Journal of Dermatology
|
November 25, 2017
Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab
R B Warren, A Brnabic, D Saure, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 27, 2013
A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis
U Mrowietz, E M G J de Jong, K Kragballe, et al.
Journal of General Internal Medicine
|
June 24, 2004
Characteristics and circumstances of falls in a hospital setting: a prospective analysis
Eileen B Hitcho, Melissa J Krauss, Stanley Birge, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 98) with videos related to
Sort By:
Page
of 10
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 15, 2018
Prioritizing topics in guideline development: results of a two-phase online survey of dermatologist members of the EADV
A Nast, M Gaskins, L Eisert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 12, 2010
On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: structure and challenges
D Pathirana, A Nast, A D Ormerod, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 21, 2009
A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: 'AGREE-ing' on a common base for European evidence-based psoriasis treatment guidelines
A Nast, P H Spuls, A D Ormerod, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 16, 2015
The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrument
R N Werner, B Marinović, S Rosumeck, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 26, 2017
Methods report: European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC
C Dressler, S Rosumeck, R N Werner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 13, 2012
Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment
T C Lucka, D Pathirana, A Sammain, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 11, 2005
Reporting and classification of patient safety events in a cardiothoracic intensive care unit and cardiothoracic postoperative care unit
Patricia A Nast, Michael Avidan, Carolyn B Harris, et al.
The British Journal of Dermatology
|
November 25, 2017
Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab
R B Warren, A Brnabic, D Saure, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 27, 2013
A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis
U Mrowietz, E M G J de Jong, K Kragballe, et al.
Journal of General Internal Medicine
|
June 24, 2004
Characteristics and circumstances of falls in a hospital setting: a prospective analysis
Eileen B Hitcho, Melissa J Krauss, Stanley Birge, et al.
Page
of 10